Ozempic Coupon in 2026: How the Savings Card Works, Who Qualifies, and What You'll Pay

Key Takeaways

• The Ozempic Savings Card from Novo Nordisk drops the monthly cost to as little as $25 per fill if you have commercial insurance and Ozempic is prescribed for type 2 diabetes.
• Medicare, Medicaid, and patients without insurance can't use the card.
• The card caps its savings at $100 per 1-month fill, $200 per 2-month fill and $300 per 3-month fill, and an activation is valid for up to 48 months from enrollment; Novo Nordisk publishes no lifetime dollar cap.
• The "Ozempic coupon" is shorthand for the Ozempic Savings Card, Novo Nordisk's manufacturer copay assistance program.
• It's not a percent-off promo code, not a paid membership, and not a free-trial card.

The short answer

The Ozempic Savings Card from Novo Nordisk drops the monthly cost to as little as $25 per fill if you have commercial insurance and Ozempic is prescribed for type 2 diabetes. Medicare, Medicaid, and patients without insurance can't use the card. The card caps its savings at $100 per 1-month fill, $200 per 2-month fill and $300 per 3-month fill, and an activation is valid for up to 48 months from enrollment; Novo Nordisk publishes no lifetime dollar cap.

Table of contents

1. The 30-second answer
2. What the Ozempic coupon actually is
3. Who qualifies (and who's blocked)
4. Real out-of-pocket scenarios
5. How to enroll and use the savings card
6. The patient assistance program (free Ozempic for low-income patients)
7. Why the savings card sometimes fails at the pharmacy
8. Off-label weight loss and why it breaks the coupon
9. Ozempic vs compounded semaglutide cost comparison
10. When to switch paths
11. Savings card terms, line by line
12. NovoCare self-pay prices (no insurance)
13. PAP income limits for 2026
14. Eight reasons the card gets rejected
15. Medicare and the $50 Bridge
16. FAQ
17. Footer disclaimers

What the Ozempic coupon actually is

The "Ozempic coupon" is shorthand for the Ozempic Savings Card, Novo Nordisk's manufacturer copay assistance program. It's not a percent-off promo code, not a paid membership, and not a free-trial card. It's a digital or physical savings card that reduces your eligible commercial-insurance copay at the pharmacy counter.

Novo Nordisk runs three separate programs that collectively get called "the coupon":

• Ozempic Savings Card (commercial insurance): as little as $25 per 1- or 3-month fill if you have commercial coverage and a type 2 diabetes diagnosis.
• Patient Assistance Program (NovoCare PAP): free Ozempic for income-qualified uninsured patients.
• NovoCare Pharmacy self-pay (no insurance needed): as of September 4, 2026, Novo Nordisk sells Ozempic pens for $199 a month for a new patient's first two fills, then $349 for 0.25 to 1 mg or $499 for 2 mg, and Ozempic tablets for $149 (1.5 mg), $199 (4 mg) or $299 (9 mg), with pricing posted as valid through December 31, 2026.

Most patients searching "ozempic coupon" want the savings card. We'll cover all three options so you can pick the right path for your situation.

Who qualifies (and who's blocked)

Eligible for the Savings Card:

• U.S. resident, age 18 or older
• Commercial or private insurance (employer, marketplace, spouse's plan)
• Ozempic prescription for type 2 diabetes (the FDA-approved indication)
• Active prescription on file at a participating pharmacy

Blocked from the Savings Card:

• Anyone enrolled in a federal health program: Medicare, Medicaid, TRICARE, VA, IHS, CHIP
• Patients without any insurance coverage
• Patients whose Ozempic prescription is written for off-label weight loss

The off-label restriction is the most common blocker. Ozempic is FDA-approved for type 2 diabetes management, not weight loss. The same active drug at higher doses is approved for chronic weight management as Wegovy. If a provider writes Ozempic for weight loss, the savings card system can flag the indication and reject the claim.

The Medicare exclusion is the second most common blocker. Federal anti-kickback rules prevent Novo Nordisk from offering manufacturer copay assistance to Medicare or Medicaid beneficiaries. There's no workaround.

Real out-of-pocket scenarios

The "as little as $25" headline is true, but real costs vary widely. Here's how the math plays out across five common situations.

Scenario 1: Commercial PPO with type 2 diabetes diagnosis, deductible met. A 52-year-old with a Cigna employer plan, A1c of 7.8, on metformin. Ozempic is on Tier 3 with $80 copay after deductible. Savings card brings it to $25. Monthly cost: $25.

Scenario 2: Commercial plan, type 2 diabetes diagnosis, deductible not met. Same patient in February with $0 of his $2,500 deductible met. Negotiated rate is $920 per fill. The savings card pays its 1-month maximum of $100. He owes $820. Novo Nordisk's terms also state that money spent while using the card may not count toward the deductible, so check with the plan.

Scenario 3: Commercial plan, off-label weight loss prescription. A 41-year-old with no diabetes diagnosis. Provider wrote Ozempic for weight management. The plan denies because the indication isn't covered. Savings card can't apply (the system flags the indication). She pays NovoCare Pharmacy's self-pay price ($199 a month for the first two fills as a new patient, then $349 for 0.25 to 1 mg, through December 31, 2026) or switches paths.

Scenario 4: Medicare Part D. A 67-year-old retiree on a Medicare Advantage plan with Part D. Ozempic for type 2 diabetes is covered with a $250 specialty copay. Savings card cannot apply. Monthly cost: $250 to $400 depending on the plan's coverage gap rules.

Scenario 5: No insurance. A 38-year-old self-employed without health coverage. Savings card requires insurance, so it doesn't help. Path is NovoCare Pharmacy self-pay ($199 for the first two fills, then $349; or the $149 Ozempic tablet), the NovoCare PAP if household income is at or below 200% of the federal poverty level, or compounded semaglutide (month-one median $197 across 14 providers in the Compounded GLP-1 Price Index, September 3, 2026).

The savings card delivers its advertised $25 monthly cost only when the patient has commercial insurance, a type 2 diabetes diagnosis, a met deductible, and Ozempic on the formulary at a reasonable tier.

How to enroll and use the savings card

Step 1: Confirm your provider has e-prescribed Ozempic to your pharmacy. The card pulls against an active prescription.

Step 2: Visit Ozempic.com or NovoCare.com. Those are Novo Nordisk's official enrollment portals. Avoid third-party "coupon" sites that don't issue the real card.

Step 3: Enroll. Provide name, email, ZIP, and confirm you're not on Medicare or Medicaid. Novo Nordisk issues a digital savings card with BIN, PCN, Group Number, and Member ID.

Step 4: Save the card. Screenshot, save to phone wallet, email a backup, print one if needed.

Step 5: At the pharmacy, hand over both your insurance card and the savings card. The pharmacist runs insurance first, then applies the savings card as secondary. Order matters.

Step 6: Verify the price before paying. A working savings card should cut your copay by up to $100 on a 1-month fill or $300 on a 3-month fill. If it didn't, ask the pharmacist to re-run.

Step 7: Track your activation window. Per NovoCare's eligibility terms, an activation is valid for up to 48 months from the date of enrollment, and Novo Nordisk reserves the right to change or end the program at any time. There is no published lifetime dollar cap; the limits are the monthly ones ($100, $200 or $300 by fill length).

The patient assistance program (free Ozempic for low-income patients)

The Novo Nordisk Patient Assistance Program (PAP) is a separate path from the savings card. It provides free Ozempic to income-qualified uninsured patients.

Eligibility (as of 2026):

• Household income at or below 200% of the federal poverty level for Ozempic specifically (Novo's PAP page sets 400% for its other products). Using the 2026 HHS guidelines, 200% is $31,920 for one person, $43,280 for two, $54,640 for three and $66,000 for four, plus $11,360 per additional person
• U.S. resident
• No prescription drug coverage, or Medicare Part D coverage; the program is for Medicare and uninsured patients only, and Medicaid, Low Income Subsidy and VA beneficiaries are not eligible
• Active Ozempic prescription for type 2 diabetes from a U.S.-licensed provider

What it provides:

• Free Ozempic for up to 12 months at a time, renewable
• Shipped directly from Novo Nordisk to the patient's address or to the prescribing provider's office
• No copay, no deductible, no insurance involvement

How to apply:

• The provider's office initiates the application at NovoCare.com on the patient's behalf
• Patient signs the financial section, provides proof of income (recent tax return, pay stubs, or unemployment documentation)
• Approval typically takes 5 to 10 business days, sometimes longer

The PAP is the lowest-cost path for any patient who qualifies. The reason it's underused is that the application is paperwork-heavy on the provider side, and many practices don't routinely volunteer it. If you're uninsured or on Medicare and your household income is at or below 200% FPL, ask your prescriber's office to file on your behalf.

Why the savings card sometimes fails at the pharmacy

When the discount doesn't apply at checkout, here's what's typically wrong:

1. Indication mismatch. If the prescription was written for weight loss instead of diabetes, the system rejects. The provider can rewrite for the diabetes indication if clinically appropriate, or the patient can switch to Wegovy (which has its own savings card for weight management) or a compounded alternative.
2. Government plan flag. Medicare Advantage and Medicaid managed care plans look like commercial cards but trigger the federal exclusion. There's no manual override.
3. Card ran as primary, not secondary. The card sits behind insurance in the claim chain. Re-run with insurance as primary.
4. Activation window expired or monthly cap reached. An activation lasts up to 48 months from enrollment; after that you must re-enroll if the program still exists. Within a month, the card pays at most $100 ($200 or $300 for 2- and 3-month fills), so a copay above that leaves you with the remainder.
5. Card expired or not enrolled. Some cards expire annually. Re-enroll if needed.
6. Pharmacy network constraints. Independent pharmacies sometimes don't process Novo Nordisk cards. Major chains (Walmart, CVS, Walgreens, Costco, Sam's Club, Kroger) reliably handle them.

If a pharmacy can't get the card to apply, calling Novo Nordisk's patient line at 1-888-693-3679 connects to a human within a few minutes who can troubleshoot in real time.

Off-label weight loss and why it breaks the coupon

The single biggest source of "Ozempic coupon" confusion is patients trying to use Ozempic for weight loss. Here's the structure.

FDA-approved indications for Ozempic:

• Type 2 diabetes (since 2017)
• Cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease (since 2020)
• Reduction in risk of kidney disease progression in adults with type 2 diabetes and chronic kidney disease (since 2024)

Notice: weight loss is not on the FDA-approved indication list for Ozempic. The same active drug, semaglutide, at a higher dose, is sold under the brand name Wegovy and is FDA-approved for chronic weight management.

When a provider writes Ozempic for weight loss in a patient without diabetes, several things break:

• Most commercial insurance plans deny because the indication isn't covered
• The Ozempic Savings Card flags the indication and rejects
• The patient ends up paying NovoCare's self-pay price ($199 for two months, then $349 to $499) or about $1,212 retail with no offer

The clinical solution is usually one of three options:

• Switch the prescription to Wegovy (with its own savings card path for weight management)
• Stay on Ozempic if the patient has documented type 2 diabetes
• Switch to a compounded semaglutide path through a state-licensed compounding pharmacy

The 2024 STEP-1 follow-up data (Wilding et al., NEJM, 2021, with extension) showed that semaglutide at the higher Wegovy dose produces about 15% mean weight loss at 68 weeks, which is what made Wegovy the brand-name pathway for weight management.

Ozempic vs compounded semaglutide cost comparison

For patients weighing brand-name Ozempic (with the savings card) against compounded semaglutide, here's a side-by-side.

Path	Monthly cost	Insurance required	FDA-approved	Indication
Ozempic, savings card, commercial insurance, deductible met, T2D diagnosis	$25	Yes (commercial)	Yes	Type 2 diabetes
Ozempic, savings card, deductible NOT met	$400 to $900 (counts toward deductible)	Yes (commercial)	Yes	Type 2 diabetes
Ozempic, off-label weight loss prescription	$199 for the first two fills, then $349 to $499 at NovoCare Pharmacy self-pay (savings card doesn't apply)	No	No (off-label)	Weight loss (off-label)
Ozempic, GoodRx	GoodRx now shows Novo's own $149 tablet and $199 pen offers instead of a coupon price; average retail $1,212 (September 4, 2026)	No	Yes	Any indication
Ozempic NovoCare PAP (free)	$0	No (must lack coverage)	Yes	Type 2 diabetes
Compounded semaglutide (FormBlends)	Current price on the product page and in our price index; the 14-provider median was $197 in month one on September 3, 2026	No	No (non-FDA approved)	Weight management or other
Wegovy (semaglutide for weight loss) with Wegovy savings card	$25 with coverage (savings capped at $100 a month), or self-pay: pen $199 for the first two fills then $349, HD 7.2 mg $399, tablet $149 to $299	Varies	Yes	Chronic weight management

The decision tree:

• If you have type 2 diabetes and commercial insurance, Ozempic with the savings card is usually cheapest.
• If you want semaglutide for weight loss, switch to Wegovy (don't fight the off-label Ozempic battle).
• If you have no insurance or your plan doesn't cover semaglutide products, compounded semaglutide is typically the most affordable path.

A licensed clinician should walk through the trade-offs before you start any path.

When to switch paths

Stay on the Ozempic savings card if:

• Type 2 diabetes is your indication
• Commercial insurance covers Ozempic
• Your deductible is met or low
• Your copay with the card is $50 or less

Switch to Wegovy with its savings card if:

• Your indication is weight loss, not diabetes
• You have commercial insurance covering Wegovy
• See our Wegovy coupon guide for the details

Apply for the NovoCare PAP (free) if:

• Your household income is at or below 200% of the federal poverty level ($31,920 for one person, $66,000 for four, 2026)
• You're uninsured or your plan doesn't cover Ozempic
• Your prescriber's office can file on your behalf

Consider compounded semaglutide if:

• Your savings card copay is over $200 monthly
• You're on Medicare and need a non-brand path
• Your insurance doesn't cover semaglutide for any indication
• You want predictable monthly pricing

Stay on Medicare-specific paths if:

• You're 65+ and Medicare Part D covers Ozempic for diabetes
• The savings card cannot apply, but the Part D copay may still be the cheapest available path

The 2026 Ozempic savings card terms, line by line

These are Novo Nordisk's own terms from the NovoCare savings-offer and eligibility pages, read on September 4, 2026. An earlier version of this page stated a $150 per-fill cap, a 24-month window and a $3,600 lifetime cap; none of those appear in the terms.

Term	What Novo Nordisk says
Price with the card	Pay as little as $25 per 1-, 2- or 3-month prescription with commercial coverage
Maximum savings	$100 per 1-month fill, $200 per 2-month fill, $300 per 3-month fill
Activation	Valid for up to 48 months from the date of enrollment
Who is eligible	U.S. or Puerto Rico residents age 18 or older with commercial insurance that covers Ozempic
Who is excluded	Anyone with Medicare, Medicaid, VA, DOD, TRICARE or other government coverage; cash-paying patients; prescriptions not covered by the plan (the offer is not valid where the entire cost is reimbursable)
Deductible	Novo states the money spent using the card does not count toward your deductible; verify with your plan
Program changes	Novo Nordisk may cancel or change the offer at any time without notice
Self-pay prices published alongside the card	Valid through December 31, 2026 ("pricing to be updated after December 31, 2026")

No insurance? NovoCare Pharmacy self-pay prices through December 31, 2026

The biggest change since this article was written is that Novo Nordisk now sells Ozempic directly at a cash price, which an earlier version of this page said it did not. As of September 4, 2026:

Product	Self-pay price per month	Notes
Ozempic pen, 0.25 mg, 0.5 mg, 1 mg	$199 for a new patient's first two fills, then $349	Through NovoCare Pharmacy home delivery or participating retail pharmacies
Ozempic pen, 2 mg	$499	Same channels
Ozempic tablet, 1.5 mg	$149	Once-daily tablet, type 2 diabetes
Ozempic tablet, 4 mg	$199
Ozempic tablet, 9 mg	$299
Ozempic retail with no offer	About $1,212 (GoodRx average retail)	Nobody should pay this in 2026

GoodRx's Ozempic page now shows these same Novo Nordisk offers at H-E-B, CVS, Walgreens, Walmart and Costco rather than a GoodRx coupon price. The self-pay path still requires a type 2 diabetes prescription; for weight loss, the equivalent self-pay ladder is Wegovy ($199 for the first two fills, then $349; tablets from $149). Compounded semaglutide ran a month-one median of $197 across 14 providers in the Compounded GLP-1 Price Index on September 3, 2026, so at the starting dose the brand pen and compounded are now within a few dollars of each other.

Ozempic patient assistance income limits for 2026 (200% of the poverty guidelines)

Novo Nordisk's PAP page sets the Ozempic threshold at 200% of the federal poverty level, tighter than the 400% that applies to most of its other products, and tighter than the 400% an earlier version of this page stated. Applied to the 2026 HHS poverty guidelines (published January 15, 2026):

Household size	100% FPL (2026)	200% FPL (Ozempic PAP cutoff)
1	$15,960	$31,920
2	$21,640	$43,280
3	$27,320	$54,640
4	$33,000	$66,000
Each additional person	add $5,680	add $11,360

Other PAP rules from the same page: applicants must be U.S. residents who are uninsured or on Medicare (Medicaid, Low Income Subsidy and VA beneficiaries do not qualify), enrollment runs 12 months at a time, and Maine and Minnesota residents must supply photo identification. Alaska and Hawaii use higher poverty guidelines; check the HHS table for those states.

Why the card was rejected at the counter: eight reasons and the fix for each

What happened	Why, per NovoCare's terms	Fix
Card never activated	The card must be enrolled before the claim	Enroll at ozempic.com or novocare.com, then re-run
Plan is government-funded	Medicare, Medicaid, VA, DOD and TRICARE are excluded, including Medicare Advantage and managed Medicaid	No fix; use Part D cost sharing, the PAP (200% FPL) or self-pay
Plan does not cover Ozempic	The offer is not valid when the plan pays nothing, or when the entire cost is reimbursable	Prior authorization or appeal first; the card only reduces a covered copay
Prescription written for weight loss	Ozempic is approved for type 2 diabetes; off-label claims are rejected	Switch to Wegovy and its own card, or self-pay
48-month activation expired	Activation is valid for up to 48 months from enrollment	Re-enroll if the program is still running
Fill exceeds three months	Savings are capped per 1-, 2- or 3-month fill	Ask the pharmacy to bill as a 3-month fill
Pharmacy ran the card as primary	The card is secondary to insurance	Re-run with insurance first, card second
Copay is bigger than the monthly cap	Savings max out at $100, $200 or $300	Nothing to fix; the remainder is yours, and it is usually a deductible problem

If the pharmacist cannot resolve it, NovoCare's patient line is 1-888-693-3679.

Medicare: no card, and the $50 GLP-1 Bridge does not include Ozempic

Two Medicare facts as of September 4, 2026. First, the savings card is unavailable to any Medicare enrollee, including Medicare Advantage, and there is no workaround. Second, the Medicare GLP-1 Bridge that started July 1, 2026 and runs through December 31, 2027 offers Wegovy, Zepbound KwikPen and Foundayo for $50 a month with prior authorization, but Ozempic is not on the list (KFF, May 11, 2026). Ozempic for type 2 diabetes stays under normal Part D cost sharing, which now runs into a $2,100 annual out-of-pocket cap for 2026. Medicare patients whose household income is at or below 200% of the poverty level ($31,920 for one person in 2026) can apply to the NovoCare PAP, which is the one Novo program that explicitly accepts Medicare enrollees.

FAQ

Is there a real Ozempic coupon for $25 per month?

Yes, if you have commercial insurance, a type 2 diabetes diagnosis, and Ozempic on your formulary. The Ozempic Savings Card brings the copay to as little as $25 per fill. Medicare, Medicaid, off-label weight loss prescriptions, and uninsured patients can't use the card.

Where do I get the official Ozempic coupon?

Ozempic.com or NovoCare.com are Novo Nordisk's official enrollment sites. Don't sign up at third-party "coupon" pages that may harvest data without issuing the real card.

Does the Ozempic savings card work with Medicare?

No. Federal law blocks manufacturer copay assistance for Medicare and Medicaid patients. Medicare patients pay their Part D cost sharing for Ozempic. The $50 Medicare GLP-1 Bridge that began July 1, 2026 covers Wegovy, Zepbound KwikPen and Foundayo, not Ozempic (KFF, May 11, 2026), and Medicare patients at or below 200% of the poverty level can apply to the NovoCare PAP instead.

Can I use the Ozempic coupon for weight loss?

No. The savings card requires Ozempic be prescribed for the FDA-approved indication of type 2 diabetes. Off-label weight loss prescriptions trigger a rejection. For weight loss, switch to Wegovy (with its own savings card) or a compounded semaglutide alternative.

What is the maximum savings on the Ozempic coupon?

The card saves up to $100 on a 1-month fill, $200 on a 2-month fill and $300 on a 3-month fill, per NovoCare's savings-offer terms as of September 4, 2026. There is no published lifetime dollar cap; an activation is valid for up to 48 months from enrollment.

Does GoodRx work for Ozempic?

Not the way it used to. As of September 4, 2026, GoodRx's Ozempic page shows Novo Nordisk's own self-pay offers ($149 tablets, $199 pens for a new patient's first two fills) at the listed pharmacies rather than a GoodRx coupon price, against an average retail of $1,212. Neither a GoodRx coupon nor the self-pay price can be combined with insurance.

Does Costco have a cheaper Ozempic price?

No longer in a way that matters. On September 4, 2026 GoodRx listed the same Novo Nordisk offers ($149 tablet, $199 pen) at Costco, Walmart, CVS, Walgreens and H-E-B, and NovoCare's self-pay price is identical at any participating pharmacy or through home delivery. The pharmacy you pick no longer changes the price.

What if my insurance doesn't cover Ozempic at all?

The savings card alone can't help (it lowers a copay; it doesn't replace coverage). Options: appeal with prior authorization, switch to a compounded semaglutide path, apply for the NovoCare PAP if income-qualified, or pay GoodRx cash price.

How long does the Ozempic savings card last?

An activation is valid for up to 48 months from the date of enrollment, per NovoCare's eligibility terms (seen September 4, 2026). Novo Nordisk can change or end the program at any time, and the self-pay prices it publishes alongside the card are posted as valid through December 31, 2026.

Does the Ozempic coupon work for chronic kidney disease patients?

Yes, if the prescription is written for the FDA-approved kidney indication (added in 2024), and the patient has commercial insurance and a type 2 diabetes diagnosis. The kidney indication doesn't change the savings card mechanics.

Can I stack the Ozempic savings card with my HSA or FSA?

You can pay your reduced copay from an HSA or FSA. The savings card itself isn't paid through HSA/FSA; it just lowers the copay you owe. The remaining out-of-pocket is HSA/FSA-eligible because Ozempic is a prescription medication.

Is there an Ozempic generic?

No. Ozempic (semaglutide) is on patent in the U.S. through approximately 2031, with some patent challenges ongoing. There's no FDA-approved generic. Compounded semaglutide is not a generic; it's a separately produced compound that's not interchangeable with Ozempic under FDA rules.

Why is my Ozempic copay high even with the coupon?

The most common reason is the deductible isn't met yet. The savings card pays up to $100 on a 1-month fill, but if your negotiated price is $900 and your deductible isn't met, you owe the rest. Other reasons: pharmacy ran the card incorrectly, off-label indication, lifetime card cap exceeded, or government plan flag.

How much does the Ozempic coupon take off?

Up to $100 on a 1-month fill, $200 on a 2-month fill or $300 on a 3-month fill, bringing an eligible commercial copay to as little as $25, per NovoCare's savings-offer terms read on September 4, 2026. If your copay is $80, you pay $25. If it is $500 because your deductible is unmet, you pay $400. The card never applies to cash purchases.

Is there a manufacturer coupon for Ozempic?

Yes, and it is the only legitimate one: the Ozempic Savings Card from Novo Nordisk, enrolled at ozempic.com or novocare.com. Third-party coupon sites are either reselling that card or offering pharmacy discount cards that no longer beat Novo's own $199 pen and $149 tablet self-pay prices (GoodRx, September 4, 2026). No coupon works with Medicare or Medicaid.

How does the Ozempic coupon work?

You enroll online, receive a digital card with BIN, PCN, group and member numbers, and the pharmacy bills your commercial insurance first and the card second. The card pays the difference between your copay and $25, up to $100, $200 or $300 depending on fill length. Activation lasts up to 48 months. It requires a type 2 diabetes prescription and a plan that covers Ozempic (NovoCare terms, September 4, 2026).

Is the $25 Ozempic card real?

Yes. Novo Nordisk's own savings-offer page says eligible commercially insured patients pay as little as $25 per 1-, 2- or 3-month prescription, subject to the $100 monthly savings cap. It is not real for people without insurance: for them the honest number is NovoCare's self-pay price, $199 a month for the first two fills of the pen or $149 for the 1.5 mg tablet as of September 4, 2026.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Novo Nordisk Ozempic prescribing information (rev. 2024), the SUSTAIN-6 cardiovascular outcomes trial (Marso et al., NEJM, 2016), the FLOW kidney outcomes trial (Perkovic et al., NEJM, 2024), the STEP-1 weight management trial (Wilding et al., NEJM, 2021), and Medicare Part D formulary data accessed Q1 2026.

Related guides

• Zepbound Coupon 2026: How the Lilly Savings Card Works, Who Qualifies, and What You'll Actually Pay
• Wegovy Coupon in 2026: How the Savings Card Works, Who Qualifies, and What You'll Pay
• Zepbound Coupon 2025: How the Savings Card Works, Who Qualifies, and What You'll Actually Pay
• Zepbound Savings Card 2026: How It Works, Who Qualifies, and What You'll Pay
• The Wegovy Manufacturer Coupon in 2026: How It Works, Who Qualifies, and Real Savings
• The Eli Lilly Mounjaro Coupon (Savings Card) in 2026: Who Qualifies, What It Saves, and What to Do If You Don't Qualify
• Tool: cost calculator

Sources

1. The Novo Nordisk Ozempic prescribing information (rev. 2024).
2. The SUSTAIN-6 cardiovascular outcomes trial (Marso et al., NEJM, 2016).
3. The FLOW kidney outcomes trial (Perkovic et al., NEJM, 2024).
4. The STEP-1 weight management trial (Wilding et al., NEJM, 2021).
5. Medicare Part D formulary data accessed Q1 2026.
6. Novo Nordisk. Ozempic savings offer and NovoCare Pharmacy self-pay prices, seen September 4, 2026. https://www.novocare.com/diabetes/products/ozempic/savings-offer.html
7. Novo Nordisk. Diabetes savings card eligibility and terms (monthly caps, 48-month activation, exclusions), seen September 4, 2026. https://www.novocare.com/eligibility/diabetes-savings-card.html
8. Novo Nordisk. Save on Ozempic, seen September 4, 2026. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
9. Novo Nordisk. Patient Assistance Program eligibility (200% FPL for Ozempic), seen September 4, 2026. https://www.novocare.com/diabetes/help-with-costs/pap.html
10. U.S. Department of Health and Human Services, ASPE. 2026 poverty guidelines, January 15, 2026. https://aspe.hhs.gov/poverty-guidelines
11. GoodRx. Ozempic prices and manufacturer offers, seen September 4, 2026. https://www.goodrx.com/ozempic
12. KFF. What to know about the BALANCE model and the Medicare GLP-1 Bridge, May 11, 2026. https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
13. Novo Nordisk. What to pay for Wegovy, seen September 4, 2026. https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html
14. FormBlends. Compounded GLP-1 Price Index, data as of September 3, 2026. https://formblends.com/report/data/compounded-glp1-price-index

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. All other brand names are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.